These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

488 related articles for article (PubMed ID: 21079037)

  • 1. International Union of Basic and Clinical Pharmacology. LXXVIII. Lysophospholipid receptor nomenclature.
    Chun J; Hla T; Lynch KR; Spiegel S; Moolenaar WH
    Pharmacol Rev; 2010 Dec; 62(4):579-87. PubMed ID: 21079037
    [TBL] [Abstract][Full Text] [Related]  

  • 2. International Union of Pharmacology. XXXIV. Lysophospholipid receptor nomenclature.
    Chun J; Goetzl EJ; Hla T; Igarashi Y; Lynch KR; Moolenaar W; Pyne S; Tigyi G
    Pharmacol Rev; 2002 Jun; 54(2):265-9. PubMed ID: 12037142
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lysophospholipid receptor nomenclature review: IUPHAR Review 8.
    Kihara Y; Maceyka M; Spiegel S; Chun J
    Br J Pharmacol; 2014 Aug; 171(15):3575-94. PubMed ID: 24602016
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacological tools for lysophospholipid GPCRs: development of agonists and antagonists for LPA and S1P receptors.
    Im DS
    Acta Pharmacol Sin; 2010 Sep; 31(9):1213-22. PubMed ID: 20729877
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lysophospholipid receptors: signalling, pharmacology and regulation by lysophospholipid metabolism.
    Meyer zu Heringdorf D; Jakobs KH
    Biochim Biophys Acta; 2007 Apr; 1768(4):923-40. PubMed ID: 17078925
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lysophospholipid receptors as potential drug targets in tissue transplantation and autoimmune diseases.
    Chun J; Rosen H
    Curr Pharm Des; 2006; 12(2):161-71. PubMed ID: 16454733
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biological effects of lysophospholipids.
    Rivera R; Chun J
    Rev Physiol Biochem Pharmacol; 2008; 160():25-46. PubMed ID: 18481029
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lysophospholipids and their receptors in the central nervous system.
    Choi JW; Chun J
    Biochim Biophys Acta; 2013 Jan; 1831(1):20-32. PubMed ID: 22884303
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Edg family G protein-coupled receptors for lysophospholipids: their signaling properties and biological activities.
    Takuwa Y; Takuwa N; Sugimoto N
    J Biochem; 2002 Jun; 131(6):767-71. PubMed ID: 12038970
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A growing family of receptor genes for lysophosphatidic acid (LPA) and other lysophospholipids (LPs).
    Chun J; Contos JJ; Munroe D
    Cell Biochem Biophys; 1999; 30(2):213-42. PubMed ID: 10356643
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lysophospholipid receptor-dependent and -independent calcium signaling.
    Meyer Zu Heringdorf D
    J Cell Biochem; 2004 Aug; 92(5):937-48. PubMed ID: 15258917
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Subtype-specific, differential activities of the EDG family receptors for sphingosine-1-phosphate, a novel lysophospholipid mediator.
    Takuwa Y; Okamoto H; Takuwa N; Gonda K; Sugimoto N; Sakurada S
    Mol Cell Endocrinol; 2001 May; 177(1-2):3-11. PubMed ID: 11377814
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lysophosphatidic acid and sphingosine 1-phosphate protection of T cells from apoptosis in association with suppression of Bax.
    Goetzl EJ; Kong Y; Mei B
    J Immunol; 1999 Feb; 162(4):2049-56. PubMed ID: 9973477
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Activation of human monocytic cells by lysophosphatidic acid and sphingosine-1-phosphate.
    Fueller M; Wang DA; Tigyi G; Siess W
    Cell Signal; 2003 Apr; 15(4):367-75. PubMed ID: 12618211
    [TBL] [Abstract][Full Text] [Related]  

  • 15. International Union of Pharmacology. XLVI. G protein-coupled receptor list.
    Foord SM; Bonner TI; Neubig RR; Rosser EM; Pin JP; Davenport AP; Spedding M; Harmar AJ
    Pharmacol Rev; 2005 Jun; 57(2):279-88. PubMed ID: 15914470
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A single amino acid determines lysophospholipid specificity of the S1P1 (EDG1) and LPA1 (EDG2) phospholipid growth factor receptors.
    Wang DA; Lorincz Z; Bautista DL; Liliom K; Tigyi G; Parrill AL
    J Biol Chem; 2001 Dec; 276(52):49213-20. PubMed ID: 11604399
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A novel approach for measuring sphingosine-1-phosphate and lysophosphatidic acid binding to carrier proteins using monoclonal antibodies and the Kinetic Exclusion Assay.
    Fleming JK; Glass TR; Lackie SJ; Wojciak JM
    J Lipid Res; 2016 Sep; 57(9):1737-47. PubMed ID: 27444045
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of the lysophospholipid receptor family and investigation of lysophospholipid-mediated responses in human macrophages.
    Duong CQ; Bared SM; Abu-Khader A; Buechler C; Schmitz A; Schmitz G
    Biochim Biophys Acta; 2004 Jun; 1682(1-3):112-9. PubMed ID: 15158762
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lysophosphatidic acid and sphingosine 1-phosphate stimulate endothelial cell wound healing.
    Lee H; Goetzl EJ; An S
    Am J Physiol Cell Physiol; 2000 Mar; 278(3):C612-8. PubMed ID: 10712250
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular identification and characterization of G protein-coupled receptors for lysophosphatidic acid and sphingosine 1-phosphate.
    An S
    Ann N Y Acad Sci; 2000 Apr; 905():25-33. PubMed ID: 10818439
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.